美国 · 股市与财经 · Quartz

Novartis is licensing an mRNA autoimmune therapy from China's Abogen for up to $7.8 billion

来源：Quartz · 美国 3 小时前

The Swiss drugmaker will pay $575 million upfront to license ABO2203, with up to $7.2 billion more tied to milestones

在 Quartz 阅读全文登录后可收藏

MediaNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (qz.com)

推荐阅读

American starts letting customers mix cash and miles for tickets

LNG Shipments Through Hormuz Hit Highest Level Since Iran War Began

TechCrunch Disrupt 2026: Blackstone’s Jas Khaira on building the next generation of AI giants

iShares 20+ Year Treasury Bond BuyWrite Strategy ETF declares monthly distribution of $0.2885

Soft Jobs Report Boosts Market Bets Fed Will Skip October Rate Increase

Business Insider

The states where borrowers owe the most in federal student loans, ranked by average balance